EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GLIS2 Promotes Epithelial‐Mesenchymal Transition and Gastric Cancer Progression by Regulating BGN to Activate the Wnt/β‐Catenin Pathway

Juan Yan, Ya-Peng Deng iD

The Kaohsiung Journal of Medical Sciences · 2026

DOI: 10.1002/kjm2.70103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2026. Verfasst von Juan Yan und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Infection Control Office, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Stomach Neoplasms, Wnt Signaling Pathway, Biglycan. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Provincial Health and Health Commission Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study elucidates the mechanism by which GLIS Family Zinc Finger 2 (GLIS2) promotes epithelial‐mesenchymal transition (EMT) in gastric cancer through biglycan (BGN) activation and Wnt/β‐catenin stimulation. By analyzing 18 pairs of GC tissues and establishing in vitro models (combining GLIS2 knockdown/BGN overexpression with Wnt pathway modulators), we demonstrated that GLIS2 directly binds to the BGN promoter to enhance its transcription, thereby activating Wnt/β‐catenin signaling and significantly promoting GC cell migration, invasion, and EMT. Functional rescue experiments confirmed that BGN overexpression reverses the inhibitory effects of GLIS2 knockdown, while the Wnt/β‐catenin inhibitor XAV‐939 effectively blocks BGN's tumor‐promoting effects. These findings establish the crucial role of the GLIS2‐BGN‐Wnt/β‐catenin axis in regulating GC EMT and identify novel potential therapeutic targets for GC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionStomach NeoplasmsWnt Signaling PathwayBiglycanHumansCell Line, Tumorbeta CateninCell MovementGene Expression Regulation, NeoplasticDisease ProgressionPromoter Regions, GeneticFemaleMaleHeterocyclic Compounds, 3-Ring

Stichwörter der Autor:innen

BGNGLIS2epithelial‐mesenchymal transitiongastric cancerprogression

Substanzen

beta CateninBiglycanXAV939Heterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • The Infection Control Office, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China.
  • Endoscopy Center, Hunan Cancer Hospital, Changsha, Hunan Province, People's Republic of China.

ORCID-Profile: Ya-Peng Deng

Förderung

  • Hunan Provincial Health and Health Commission Scientific Research Project

Zitieren

APA

Yan, J., & Deng, Y. P. (2026). GLIS2 Promotes Epithelial‐Mesenchymal Transition and Gastric Cancer Progression by Regulating BGN to Activate the Wnt/β‐Catenin Pathway. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70103

Vancouver

Yan J, Deng YP. GLIS2 Promotes Epithelial‐Mesenchymal Transition and Gastric Cancer Progression by Regulating BGN to Activate the Wnt/β‐Catenin Pathway. The Kaohsiung Journal of Medical Sciences. 2026. doi:10.1002/kjm2.70103

BibTeX
@article{Yan2026,
  author = {Yan, Juan and Deng, Ya-Peng},
  title = {GLIS2 Promotes Epithelial‐Mesenchymal Transition and Gastric Cancer Progression by Regulating BGN to Activate the Wnt/β‐Catenin Pathway},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2026},
  doi = {10.1002/kjm2.70103}
}
Kostenlos starten →